Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men

Objectives. We performed continuous glucose monitoring (CGM) to define the features of patients with newly diagnosed type 2 diabetes (T2D) before and after Continuous Subcutaneous Insulin Infusion (CSII) therapy. Methods. This was a retrospective analysis. Newly diagnosed T2D patients (106) were adm...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng-fei Li, Bing-li Liu, Hong-hong Zhu, Ting Li, Wen-li Zhang, Xiao-fei Su, Jin-dan Wu, Xue-qin Wang, Ning Xu, Wei-Nan Yu, Qun Yuan, Guan-cheng Qi, Lei Ye, Kok-Onn Lee, Jian-hua Ma
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/2740372
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549337216843776
author Feng-fei Li
Bing-li Liu
Hong-hong Zhu
Ting Li
Wen-li Zhang
Xiao-fei Su
Jin-dan Wu
Xue-qin Wang
Ning Xu
Wei-Nan Yu
Qun Yuan
Guan-cheng Qi
Lei Ye
Kok-Onn Lee
Jian-hua Ma
author_facet Feng-fei Li
Bing-li Liu
Hong-hong Zhu
Ting Li
Wen-li Zhang
Xiao-fei Su
Jin-dan Wu
Xue-qin Wang
Ning Xu
Wei-Nan Yu
Qun Yuan
Guan-cheng Qi
Lei Ye
Kok-Onn Lee
Jian-hua Ma
author_sort Feng-fei Li
collection DOAJ
description Objectives. We performed continuous glucose monitoring (CGM) to define the features of patients with newly diagnosed type 2 diabetes (T2D) before and after Continuous Subcutaneous Insulin Infusion (CSII) therapy. Methods. This was a retrospective analysis. Newly diagnosed T2D patients (106) were admitted from eight centers in China. They were divided into a younger patient group (<60 years) and an older patient group (≥60 years). Each group was further divided into male and female patients. CSII therapy was maintained for 3 weeks after the glycemic target was reached. CGM was performed 2 times before and after completion of insulin treatment. Results. CGM data showed the expected significant improvement of mean amplitude glycemic excursion (MAGE) with CSII therapy. The older patients had lower hourly glucose concentrations from 0200 to 0700 o’clock compared to the younger patients at baseline. Surprisingly, in the older patient group, the male patients had a potential risk of hypoglycemia after CSII therapy, especially during periods from 2300 to 2400 and 0400 to 0600. Conclusions. Our data suggested that older male patients with newly diagnosed T2D may have lower nocturnal glucose concentrations. This may potentially increase the risk of nocturnal hypoglycemia during CSII therapy. This study was registered with Chinese Clinical Trial Registry, number CliCTR-TRC-11001218.
format Article
id doaj-art-dcc928ddd26c4fe8aeded7096e95be34
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-dcc928ddd26c4fe8aeded7096e95be342025-02-03T06:11:38ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/27403722740372Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older MenFeng-fei Li0Bing-li Liu1Hong-hong Zhu2Ting Li3Wen-li Zhang4Xiao-fei Su5Jin-dan Wu6Xue-qin Wang7Ning Xu8Wei-Nan Yu9Qun Yuan10Guan-cheng Qi11Lei Ye12Kok-Onn Lee13Jian-hua Ma14Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, The First People’s Hospital of Nantong, Nantong, ChinaDepartment of Endocrinology, The First People’s Hospital of Lianyungang, Lianyungang, ChinaDepartment of Endocrinology and Metabolism, Huai’an Hospital Affiliated to Xuzhou Medical College and Huai’an Second People’s Hospital, Huai’an, ChinaDepartment of Endocrinology, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, ChinaDepartment of Endocrinology, Lianyungang Oriental Hospital, Lianyungang, ChinaNational Heart Research Institute Singapore, National Heart Centre Singapore, SingaporeDepartment of Medicine, National University of Singapore, SingaporeDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaObjectives. We performed continuous glucose monitoring (CGM) to define the features of patients with newly diagnosed type 2 diabetes (T2D) before and after Continuous Subcutaneous Insulin Infusion (CSII) therapy. Methods. This was a retrospective analysis. Newly diagnosed T2D patients (106) were admitted from eight centers in China. They were divided into a younger patient group (<60 years) and an older patient group (≥60 years). Each group was further divided into male and female patients. CSII therapy was maintained for 3 weeks after the glycemic target was reached. CGM was performed 2 times before and after completion of insulin treatment. Results. CGM data showed the expected significant improvement of mean amplitude glycemic excursion (MAGE) with CSII therapy. The older patients had lower hourly glucose concentrations from 0200 to 0700 o’clock compared to the younger patients at baseline. Surprisingly, in the older patient group, the male patients had a potential risk of hypoglycemia after CSII therapy, especially during periods from 2300 to 2400 and 0400 to 0600. Conclusions. Our data suggested that older male patients with newly diagnosed T2D may have lower nocturnal glucose concentrations. This may potentially increase the risk of nocturnal hypoglycemia during CSII therapy. This study was registered with Chinese Clinical Trial Registry, number CliCTR-TRC-11001218.http://dx.doi.org/10.1155/2017/2740372
spellingShingle Feng-fei Li
Bing-li Liu
Hong-hong Zhu
Ting Li
Wen-li Zhang
Xiao-fei Su
Jin-dan Wu
Xue-qin Wang
Ning Xu
Wei-Nan Yu
Qun Yuan
Guan-cheng Qi
Lei Ye
Kok-Onn Lee
Jian-hua Ma
Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
Journal of Diabetes Research
title Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
title_full Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
title_fullStr Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
title_full_unstemmed Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
title_short Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
title_sort continuous glucose monitoring in newly diagnosed type 2 diabetes patients reveals a potential risk of hypoglycemia in older men
url http://dx.doi.org/10.1155/2017/2740372
work_keys_str_mv AT fengfeili continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT bingliliu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT honghongzhu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT tingli continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT wenlizhang continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT xiaofeisu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT jindanwu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT xueqinwang continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT ningxu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT weinanyu continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT qunyuan continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT guanchengqi continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT leiye continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT kokonnlee continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen
AT jianhuama continuousglucosemonitoringinnewlydiagnosedtype2diabetespatientsrevealsapotentialriskofhypoglycemiainoldermen